SCHEMBL22686153

SCHEMBL22686153

O=S1(=O)NC=Nc2c[c]ccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22686137 0.68
SCHEMBL9264880 0.66 CHRNB2 (0.32)
SCHEMBL7858362 0.60
SCHEMBL9317948 0.59
SCHEMBL8810914 0.59 CA12 (0.55)
SCHEMBL21054186 0.58 CA2 (0.31)
SCHEMBL21054310 0.58
SCHEMBL4129020 0.57 CA1 (0.58)
SCHEMBL5907951 0.56 CA12 (0.55)
SCHEMBL5297954 0.56 BRD4 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200369667-A1 HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS ANGEX PHARMACEUTICAL, INC. 2020-11-26 US disclosed
CN-111741964-A Heterocyclic compounds as PRMT5 inhibitors 安杰斯制药公司 2020-10-02 CN disclosed